Case report on CoreFlow Soft Stent® published

In Mega Journal of Case Reports a case report on ProstaLund’s CoreFlow Soft Stent has been published.

Dr. Sonny Schelin has got a case report, ”CoreFlow Soft Stent® used as a Persistent Catheter Substitute for 11 Months Waiting for Surgery: Spontaneous Micturition and Full Continence” published in the journal Mega Journal of Case Reports.

The report describes a patient with urinary retention, caused by benign prostatic hyperplasia, who, while waiting for surgical treatment during the pandemic years, used 11 CoreFlow instead of indwelling urinary catheters.

With the help of CoreFlow, the patient was symptom-free, satisfied and emptied the bladder spontaneously for almost a year with the help of the stents that remedied the obstruction through the prostate. Not a single episode of urinary retention or urinary tract infection was recorded during the stent period.

Schelin concludes in the report that CoreFlow can eliminate the discomfort of indwelling catheters and reduce the risk of urinary tract infections for patients waiting for active treatment.

“CoreFlow is a fantastic alternative to all men with urinary retention who want to avoid an indwelling catheter. I am happy together with every patient who is given this opportunity.”, says CEO Johan Wennerholm in a comment.

https://megajournalofcasereports.com/wp-content/uploads/2023/05/MJCR-6-2105.pdf

For further information, please contact:

Johan Wennerholm,  CEO
Tel. +46 (0) 730 429997
Email: johan.wennerholm@prostalund.com

About ProstaLund

ProstaLund AB is a Swedish medical technology company and a leading developer and manufacturer of innovative urological devices and treatments. The company’s lead product, CoreTherm, is a patented Thermotherapy treatment method for Benign Prostatic Hyperplasia (BPH) which can be tailored to suit the needs of each individual patient. CoreTherm is used today in hospitals and clinics in Sweden and worldwide. ProstaLund is listed on the Nasdaq First North Growth Market.

Certified Adviser:
Västra Hamnen Corporate Finance AB
Phone: +46 40 200 250
E-mail: ca@vhcorp.se

/af

CoreFlow® lanceres i Sverige den 2. oktober 2020

Den 2. oktober 2020 lancerer ProstaLund CoreFlow® Soft Stent i Sverige. Landets læger og sygeplejersker inden for urologi har modtaget en invitation til et lanceringsmøde i Lund, et møde, der også vil kunne følges på et link.

I kølvandet på covid-19 har ProstaLund fremskyndet salgs- og marketingarbejdet hos CoreFlow® Soft Stent, et unikt nyt produkt til markedet, som virksomheden af ​​forskellige årsager ikke tidligere har kommercialiseret. CoreFlow® Soft Stent blev opfundet af Dr. Sonny Schelin, hvor ProstaLund har patenterne og har udviklet produktet.

Hans Östlund VD, ProstaLund:

“CoreFlow har multipla användningsområden som i en tid med växande vårdköer och krav på kostnads- och resurseffektivitet inom sjukvården kommer att bli ett mycket värdefullt tillskott för såväl vårdpersonal som patienter med avflödeshinder. I oktober lanseras produkten i Sverige och vi förbereder för en introduktion i de nordiska grannländerna kort därefter.”

Læs mere

/af